Pyrazole derivatives for the inhibition of CDK' s and GSK' s

Details for Australian Patent Application No. 2006207311 (hide)

Owner Astex Therapeutics Limited

Inventors Navarro, Eva Figueroa; Woodhead, Andrew James; Wyatt, Paul Graham; Gill, Adrian Liam; Trewartha, Gary; O'Brien, Michael Alistair; Berdini, Valerio; Phillips, Theresa Rachel

Agent Davies Collison Cave

Pub. Number AU-A-2006207311

PCT Pub. Number WO2006/077414

Priority 0501480.8 22.01.05 GB; 60/651,339 09.02.05 US; 0501748.8 27.01.05 GB; 60/646,217 21.01.05 US

Filing date 20 January 2006

Wipo publication date 27 July 2006

International Classifications

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A01N 43/56 (2006.01) Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds

A61K 31/44 (2006.01) - Non-condensed pyridines

A61P 35/00 (2006.01) Antineoplastic agents

Event Publications

16 August 2007 PCT application entered the National Phase

  PCT publication WO2006/077414 Priority application(s): WO2006/077414

16 September 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(c). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006207313-Pyrazole derivatives for the inhibition of CDK' s and GSK' s

2006207308-Polypeptide mutagenesis method